Literature DB >> 9673320

Contrast media and the brain. The basis of CT and MR imaging enhancement.

M R Sage1, A J Wilson, R Scroop.   

Abstract

Blood, cerebrospinal fluid, and extracellular fluid of the parenchyma form the fluid compartments of the brain with three interfaces between--the blood-brain interface, the CSF-brain interface, and the blood-CSF interface. These and other issues are discussed in this article.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9673320

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN： 1052-5149            Impact factor:   2.264


  13 in total

1.  Nonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative Factors.

Authors:  Vaios Hatzoglou; Sasan Karimi; Eli L Diamond; Eric Lis; George Krol; Andrei I Holodny; Robert J Young
Journal:  Neurohospitalist       Date:  2016-01

2.  Comparison of post-contrast 3D-T1-MPRAGE, 3D-T1-SPACE and 3D-T2-FLAIR MR images in evaluation of meningeal abnormalities at 3-T MRI.

Authors:  Balaji Jeevanandham; Tejas Kalyanpur; Prashant Gupta; Mathew Cherian
Journal:  Br J Radiol       Date:  2017-04-26       Impact factor: 3.039

3.  Decreased infarct volume and intracranial hemorrhage associated with intra-arterial nonionic iso-osmolar contrast material in an MCA occlusion/reperfusion model.

Authors:  H Morales; A Lu; Y Kurosawa; J F Clark; J Leach; K Weiss; T Tomsick
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

4.  Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.

Authors:  T A Tomsick; L D Foster; D S Liebeskind; M D Hill; J Carrozella; M Goyal; R von Kummer; A M Demchuk; I Dzialowski; V Puetz; T Jovin; H Morales; Y Y Palesch; J Broderick; P Khatri; S D Yeatts
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

5.  Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions.

Authors:  Andrew A Kanner; Nicola Marchi; Vincent Fazio; Marc R Mayberg; Michael T Koltz; Vitaly Siomin; Glen H J Stevens; Thomas Masaryk; Barbara Aumayr; Barbara Ayumar; Michael A Vogelbaum; Gene H Barnett; Damir Janigro
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

6.  Flat detector angio-CT following intra-arterial therapy of acute ischemic stroke: identification of hemorrhage and distinction from contrast accumulation due to blood-brain barrier disruption.

Authors:  T Kau; M Hauser; S M Obmann; M Niedermayer; J R Weber; K A Hausegger
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-19       Impact factor: 3.825

7.  Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T.

Authors:  H Fukuoka; T Hirai; T Okuda; Y Shigematsu; A Sasao; E Kimura; T Hirano; S Yano; R Murakami; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-24       Impact factor: 3.825

8.  Early Detection of Malignant Transformation in Resected WHO II Low-Grade Glioma Using Diffusion Tensor-Derived Quantitative Measures.

Authors:  Martin T Freitag; Klaus H Maier-Hein; Francisczek Binczyk; Frederik B Laun; Christian Weber; David Bonekamp; Rafal Tarnawski; Barbara Bobek-Billewicz; Joanna Polanska; Henryk Majchrzak; Bram Stieltjes
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

9.  Exclusion of a brain lesion: is intravenous contrast administration required after normal precontrast magnetic resonance imaging?

Authors:  E J Ives; N Rousset; N Heliczer; M E Herrtage; A E Vanhaesebrouck
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

10.  Importance of Contrast-Enhanced Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging in Various Intracranial Pathologic Conditions.

Authors:  Eun Kyoung Lee; Eun Ja Lee; Sungwon Kim; Yong Seok Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.